Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: Study with TAT peptide-conjugated nanoparticles

Molecular Pharmaceutics

Volumn 6, Issue 5, 2009, Pages 1311-1320

  Peetla, Chiranjeevi ^a   Rao, Kavitha S ^a   Labhasetwar, Vinod ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cell penetrating peptides; Drug delivery; Nanocarriers; Nanotoxicity; Polymers

Indexed keywords

NANOPARTICLE; PHOSPHOLIPID; POLYLACTIDE; RITONAVIR; TRANSACTIVATING TRANSCRIPTOR PEPTIDE CONJUGATED NANOPARTICLE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ATOMIC FORCE MICROSCOPY; CELL MEMBRANE; CELL TRANSPORT; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONJUGATION; CONTROLLED STUDY; ENDOTHELIAL CELL MODEL MEMBRANE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMAGE ANALYSIS; MEMBRANE MODEL; MOLECULAR INTERACTION; PRIORITY JOURNAL; SURFACE PROPERTY; VASCULAR ENDOTHELIUM;

BIOLOGICAL TRANSPORT, ACTIVE; BIOPHYSICAL PHENOMENA; CELLS, CULTURED; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; HUMANS; MEMBRANES, ARTIFICIAL; MICROSCOPY, ATOMIC FORCE; MODELS, MOLECULAR; NANOPARTICLES; NANOTECHNOLOGY; POLYESTERS; RITONAVIR; STATIC ELECTRICITY; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; THERMODYNAMICS;

EID: 68149161590     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp900011h     Document Type: Conference Paper

References (44)

1. Deshayes, S.; Simeoni, F.; Morris, M. C.; Divita, G.; Heitz, F. Peptide-mediated delivery of nucleic acids into mammalian cells. Methods Mol. Biol. 2007, 386, 299-308.
2. Deshayes, S.; Morris, M.; Heitz, F.; Divita, G. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv. Drug Delivery Rev. 2008, 60, 537-547. (Pubitemid 351222678)
3. Vasir, J. K.; Labhasetwar, V. Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials 2008, 29, 4244-4252.
4. Panyam, J.; Labhasetwar, V. Dynamics of endocytosis and exocytosis of poly(D, L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm. Res. 2003, 20, 212-220. (Pubitemid 36277684)
5. Trehin, R.; Merkle, H. P. Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur. J. Pharm. Biopharm. 2004, 58, 209-223.
6. Yezhelyev, M.; Yacoub, R.; O'Regan, R. Inorganic nanoparticles for predictive oncology of breast cancer. Nanomedicine 2009, 4, 83-103.
7. Derossi, D.; Calvet, S.; Trembleau, A.; Brunissen, A.; Chassaing, G.; Prochiantz, A. Cell internalization of the third helix of the antennapedia homeodomain is receptor-independent. J. Biol. Chem. 1996, 271, 18188-18193. (Pubitemid 26250811)
8. Soomets, U.; Lindgren, M.; Gallet, X.; Hallbrink, M.; Elmquist, A.; Balaspiri, L.; Zorko, M.; Pooga, M.; Brasseur, R.; Langel, U. Deletion analogues of transportan. Biochim. Biophys. Acta, Biomembr. 2000, 1467, 165-176.
9. Yandek, L. E.; Pokorny, A.; Floren, A.; Knoelke, K.; Langel, U.; Almeida, P. F. F. Mechanism of the cell-penetrating peptide transportan 10 permeation of lipid bilayers. Biophys. J. 2007, 92, 2434-2444.
10. Ziegler, A.; Blatter, X. L.; Seelig, A.; Seelig, J. Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis. Biochemistry 2003, 42, 9185-9194. (Pubitemid 36935428)
11. Eum, W. S.; Jang, S. H.; Kim, D. W.; Choi, H. S.; Choi, S. H.; Kim, S. Y.; An, J. J.; Lee, S. H.; Han, K.; Kang, J. H.; Kang, T. C.; Won, M. H.; Cho, Y. J.; Choi, J. H.; Kim, T. Y.; Park, J.; Choi, S. Y. Enhanced transduction of Cu, Zn-superoxide dismutase with HIV-1 Tat protein transduction domains at both termini. Mol. Cells 2005, 19, 191-197.
12. Al-Taei, S.; Penning, N. A.; Simpson, J. C.; Futaki, S.; Takeuchi, T.; Nakase, I.; Jones, A. T. Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors. Bioconjugate Chem. 2006, 17, 90-100.
13. Chen, B.; Liu, Q.; Zhang, Y.; Xu, L.; Fang, X. Transmembrane delivery of the cell-penetrating peptide conjugated semiconductor quantum dots. Langmuir 2008, 24, 11866-11871.
14. Christian, N. A.; Milone, M. C.; Ranka, S. S.; Li, G.; Frail, P. R.; Davis, K. P.; Bates, F. S.; Therien, M. J.; Ghoroghchian, P. P.; June, C. H.; Hammer, D. A. Tat-functionalized near-infrared emissive polymersomes for dendritic cell labeling. Bioconjugate Chem. 2007, 18, 31-40.
15. Vives, E.; Brodin, P.; Lebleu, B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 1997, 272, 16010-16017. (Pubitemid 27265584)
16. Hallbrink, M.; Floren, A.; Elmquist, A.; Pooga, M.; Bartfai, T.; Langel, U. Cargo delivery kinetics of cell-penetrating peptides. Biochim. Biophys. Acta 2001, 1515, 101-109.
17. Torchilin, V. P. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv. Drug Delivery Rev. 2008, 60, 548-558. (Pubitemid 351215572)
18. Vives, E. Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions. J. Mol. Recognit. 2003, 16, 265-271. (Pubitemid 37231695)
19. Zorko, M.; Langel, U. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv. Drug Delivery Rev. 2005, 57, 529-545. (Pubitemid 40255559)
20. Alsenz, J.; Steffen, H.; Alex, R. Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers. Pharm. Res. 1998, 15, 423-428. (Pubitemid 28175123)
21. Rao, K. S.; Reddy, M. K.; Horning, J. L.; Labhasetwar, V. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 2008, 29, 4429-4438.
22. Leray, C.; Andriamampandry, M.; Gutbier, G.; Cavadenti, J.; KleinSoyer, C.; Gachet, C.; Cazenave, J. P. Quantitative analysis of vitamin E, cholesterol and phospholipid fatty acids in a single aliquot of human platelets and cultured endothelial cells. J. Chromatogr. B 1997, 696, 33-42.
23. Peetla, C.; Labhasetwar, V. Biophysical characterization of nanoparticle-endothelial model cell membrane interactions. Mol. Pharmaceutics 2008, 5, 418-429. (Pubitemid 351929826)
24. Sahoo, S. K.; Panyam, J.; Prabha, S.; Labhasetwar, V. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Controlled Release 2002, 82, 105-114. (Pubitemid 34775052)
25. Al-Taei, S.; Penning, N. A.; Simpson, J. C.; Futaki, S.; Takeuchi, T.; Nakase, I.; Jones, A. T. Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors. Bioconjugate Chem. 2006, 17, 90-100.
26. Ryu, J.; Han, K.; Park, J.; Choi, S. Y. Enhanced uptake of a heterologous protein with an HIV-1 Tat protein transduction domains (PTD) at both termini. Mol. Cells 2003, 16, 385-391.
27. Tiriveedhi, V.; Butko, P. A fluorescence spectroscopy study on the interactions of the TAT-PTD peptide with model lipid membranes. Biochemistry 2007, 46, 3888-3895. (Pubitemid 46493489)
28. Hyndman, L.; Lemoine, J. L.; Huang, L.; Porteous, D. J.; Boyd, A. C.; Nan, X. HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. J. Controlled Release 2004, 99, 435-444. (Pubitemid 39296912)
29. Peetla, C.; Labhasetwar, V. Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake. Langmuir 2009, 25, 2369-2377.
30. Brooks, H.; Lebleu, B.; Vives, E. Tat peptide-mediated cellular delivery: back to basics. Adv. Drug Delivery Rev. 2005, 57, 559-577. (Pubitemid 40255561)
31. Ren, L.; Tsuru, K.; Hayakawa, S.; Osaka, A. Synthesis and characterization of gelatin-siloxane hybrids derived through solgel procedure. J. Sol-Gel Sci. Technol. 2001, 21, 115-121.
32. Mathew, C. J.; Wilce, M.-I. A.; Milton, T. W. Heam. Physicochemical basis of amino acid hydrophobicity scales: Evaluation of four new scales of amino acid hydrophobicity coefficients derived from RP-HPLC of peptides. Anal. Chem. 1995, 67, 1210-1295.
33. Dennison, S. R.; Baker, R. D.; Nicholl, I. D.; Phoenix, D. A. Interactions of cell penetrating peptide Tat with model membranes: A biophysical study. Biochem. Biophys. Res. Commun. 2007, 363, 178-182. (Pubitemid 47430110)
34. Nagy, I. B.; Alsina, M. A.; Haro, I.; Reig, F.; Hudecz, F. Phospholipid-model membrane interactions with branched polypeptide conjugates of a hepatitis A virus peptide epitope. Bioconjugate Chem. 2000, 11, 30-38. (Pubitemid 30063340)
35. Wimley, W. C.; White, S. H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 1996, 3, 842-848.
36. White, S. H.; Wimley, W. C. Hydrophobic interactions of peptides with membrane interfaces. Biochim. Biophys. Acta 1998, 1376, 339-352.
37. Dathe, M.; Schumann, M.; Wieprecht, T.; Winkler, A.; Beyermann, M.; Krause, E.; Matsuzaki, K.; Murase, O.; Bienert, M. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry 1996, 35, 12612-12622. (Pubitemid 26318059)
38. Wieprecht, T.; Dathe, M.; Schumann, M.; Krause, E.; Beyermann, M.; Bienert, M. Conformational and functional study of magainin 2 in model membrane environments using the new approach of systematic double-D-amino acid replacement. Biochemistry 1996, 35, 10844-10853.
39. Van Mau, N.; Vie, V.; Chaloin, L.; Lesniewska, E.; Heitz, F.; Le Grimellec, C. Lipid-induced organization of a primary amphipathic peptide: a coupled AFM-monolayer study. J. Membr. Biol. 1999, 167, 241-249. (Pubitemid 29081360)
40. Wender, P. A.; Mitchell, D. J.; Pattabiraman, K.; Pelkey, E. T.; Steinman, L.; Rothbard, J. B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 13003-13008.
41. Futaki, S.; Ohashi, W.; Suzuki, T.; Niwa, M.; Tanaka, S.; Ueda, K.; Harashima, H.; Sugiura, Y. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjugate Chem. 2001, 12, 1005-1011. (Pubitemid 33136872)
42. Chen, L. L.; Frankel, A. D.; Harder, J. L.; Fawell, S.; Barsoum, J.; Pepinsky, B. Increased cellular uptake of the human immunodeficiency virus-1 Tat protein after modification with biotin. Anal. Biochem. 1995, 227, 168-175.
43. Qaddoumi, M. G.; Ueda, H.; Yang, J.; Davda, J.; Labhasetwar, V.; Lee, V. H. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharm. Res. 2004, 21, 641-648.
44. Santra, S.; Yang, H.; Dutta, D.; Stanley, J. T.; Holloway, P. H.; Tan, W.; Moudgil, B. M.; Mericle, R. A. TAT conjugated, FITC doped silica nanoparticles for bioimaging applications. Chem. Commun. 2004, 2810-2811.